InvestorsHub Logo
Replies to #86453 on Biotech Values
icon url

rkrw

11/18/09 12:13 AM

#86454 RE: drbio45 #86453

Given your scathing review, I think i will buy heavily tomorrow. :)
icon url

turtlepower

11/18/09 12:17 AM

#86455 RE: drbio45 #86453

their pfs was actually less then the carboplatin.



Did you mean oxali? PFS for pico regimen was 6.8 months vs 7 months for the oxali regimen, a matter of days. 7 patients on oxali discontinued while none on pico did. The side effect profile for pico is a lot better. The data however seems pretty identical to the asco data.